Physician profile
Robert P Farhat
NPI 1033239959
$4,055.33
in general payments reported to CMS, 2019-2025
49 companies · $546 in 2025
The $546 reported for 2025 was more than what 80% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $798 · 2020: $206 · 2021: $536 · 2022: $1,002 · 2023: $416 · 2024: $551 · 2025: $546.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,513.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,513.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $922.44 | 2019-2024 | Senza |
| Scilex Pharmaceuticals INC. | $327.88 | 2019-2023 | Ztlido |
| Boston Scientific Corporation | $241.64 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Watchman Access System |
| Abbvie INC. | $227.46 | 2021-2025 | |
| Horizon Therapeutics Plc | $171.54 | 2019-2021 | |
| Allergan, INC. | $169.55 | 2019-2022 | |
| Avanir Pharmaceuticals, INC. | $157.42 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $155.15 | 2019-2021 | |
| Globus Medical, INC. | $149.24 | 2025 | Senza |
| Abbott Laboratories | $127.04 | 2019-2025 | Proclaim |
| Merz Pharmaceuticals, LLC | $118.45 | 2022-2023 | Xeomin |
| Medtronic, INC. | $116.76 | 2023-2025 | Intellis Adaptivestim, Inceptiv |
| Saluda Medical Americas, INC. | $106.99 | 2025 | Evoke |
| Ucb, INC. | $76.49 | 2021-2022 | |
| Si-Bone, INC. | $73.11 | 2020-2025 |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Farhat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.